Skip to main content

Table 1 Clinical characteristic of the study subjects

From: DIA proteomics analysis through serum profiles reveals the significant proteins as candidate biomarkers in women with PCOS

 

Control (n = 31)

PCOS (n = 31)

p value

Age [years]

24.52 ± 2.31

24.20 ± 4.49

0.750

BMI [kg/m2]

20.48 ± 2.67

22.27 ± 3.56

0.081

Fasting glucose [mmol/L]

4.68 ± 0.42

5.25 ± 1.20

0.026 < 0.05

FSH [IU/L]

5.15 ± 1.32

5.59 ± 2.86

0.440

LH [IU/L]

5.85 ± 2.74

9.82 ± 8.57

0.017 < 0.05

LH/FSH

1.14 ± 0.50

1.73 ± 0.97

0.003 < 0.01

PRL [mIU/L]

466.83 ± 231.05

309.64 ± 158.59

0.003 < 0.01

E2 [pmol/L]

209.95 ± 127.20

220.25 ± 246.80

0.837

T [nmol/L]

1.12 ± 0.40

1.65 ± 0.67

< 0.001

P [nmol/L]

0.93 ± 0.36

1.05 ± 0.80

0.451

TC [mmol/L]

4.44 ± 0.63

4.65 ± 0.76

0.306

TG [mmol/L]

0.75 ± 0.29

1.13 ± 0.51

0.002 < 0.05

HDL-c [mmol/L]

2.23 ± 0.52

1.46 ± 0.41

< 0.001

LDL-c [mmol/L]

1.69 ± 0.29

2.54 ± 0.62

< 0.001